What question did this study set out to answer?

This research explores the experiences of younger myeloma patients enrolled in high-deductible health plans.

December 8, 2025Blood

Experiences of patients with multiple myeloma enrolled in high-deductible health plans: A mixed-methods study

View Full Paper

Ask AI

Bookmark

Authors

Mixed-methods study reveals high out-of-pocket expenditures and financial toxicity among myeloma patients in high-deductible health plans.

This research explores the experiences of younger myeloma patients enrolled in high-deductible health plans.
Mixed-methods design encompassing surveys and semi-structured qualitative interviews.
Participants included myeloma patients from the Plasma Cell Dyscrasia Tissue and Data Registry.
A focus on financial experiences and insurance plan choices among patients enrolled in HDHPs.
31% of respondents were insured primarily through Medicare or Medicaid, 67% through commercial insurance.
60% of commercially insured patients reported being in an HDHP.
HDHPs presented both cost-saving potential and increased financial burdens for patients.

Shah et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Mixed-methods study reveals high out-of-pocket expenditures and financial toxicity among myeloma patients in high-deductible health plans.